Mesirow Financial Investment Management, Inc. Astrazeneca PLC Transaction History
Mesirow Financial Investment Management, Inc.
- $5.23 Billion
- Q3 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 9,152 shares of AZN stock, worth $818,188. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,152
Previous 8,335
9.8%
Holding current value
$818,188
Previous $582,000
20.62%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,497Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...